'Pioneering' surgery means young cancer patient may have children
Related Stories
Teenager becomes first person to have testicular tissue transplant in UK
Operation on 19-year-old who had no sperm after chemotherapy offers hope of preserving children’s fertility after cancer treatment Surgeons have performed the first testicular tissue transplant on a teenager in the UK, offering hope that boys left infertile by chemotherapy could one day have biological children. The 19-year-old had his tissue removed and frozen three years ago before undergoing treatment for a serious blood disorder. He said he was “incredibly grateful” to the medical team...
Teenager becomes first person to have testicular tissue transplant in UK
Operation on 19-year-old who had no sperm after chemotherapy offers hope of preserving children’s fertility after cancer treatment Surgeons have performed the first testicular tissue transplant on a teenager in the UK, offering hope that boys left infertile by chemotherapy could one day have biological children. The 19-year-old had his tissue removed and frozen three years ago before undergoing treatment for a serious blood disorder. He said he was “incredibly grateful” to the medical team...
Woman loses medical negligence claim over partially amputated leg
NSW Supreme Court rules doctors were not negligent over partial amputation of woman's leg In short: Vesna Zvicer has lost a medical negligence case against the Hunter New England health district, after alleging doctors wrongfully amputated her lower left leg. Ms Zvicer said pressure-relieving surgery should have instead been performed, but a Supreme Court justice disagreed. Ms Zvicer has been ordered to pay the health district's legal costs.
FDA says it will complete safety review of abortion pill in March
The Food and Drug Administration expects to complete its safety review of the abortion pill mifepristone in March, according to a court document the Justice Department filed Wednesday. In the filing, the FDA said it plans to compare mifepristone’s safety to that of surgical abortions through 10 weeks’ gestation. Its review will measure the frequency of side effects among roughly 100,000 women who took mifepristone, it said.